Data Foundry

Drug recalls 2018

Levetiracetam in 0 — Class II drug recall D-0705-2018

Terminated recall by AuroMedics Pharma LLC, reported 2018-05-09, distributed nationwide. Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer b

Recall numberD-0705-2018
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAuroMedics Pharma LLC, East Windsor, NJ, United States
Recall initiated2018-03-27
Classified2018-05-03
Reported by FDA2018-05-09
Terminated2022-02-18
DistributedNationwide (US)
Quantity261,250 bags
Reason classesmicrobial contamination, sterility, packaging
Pathogensmold
NDC55150-0246, 55150-0246-47, 55150-0247, 55150-0247-47, 55150-0248, 55150-0248-47
Lot numbers12/18, CLV160016, CLV160017, CLV160018, CLV160019, CLV160020, CLV160021, CLV160031, CLV160032, CLV170001, CLV170008, CLV170009, CLV170020, CLV170021, CLV170022
Expiration dates2018-09-20, 2018-10-20, 2018-11-20, 2019-04-20, 2019-10-20

Product

Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL), For Intravenous Infusion Only, Distributed By: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-246-47.

Reason for recall

Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0705-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.